Categories: News

EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023

Recent Posts

Neogen® Announces Change to Second-Quarter Earnings Release Date

LANSING, Mich., Jan. 2, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that, due to…

4 hours ago

ModMed Achieves ASTP/ONC Certification Related to AI-Powered Scribe, Revolutionizing Provider Efficiency and Patient Care

BOCA RATON, Fla.--(BUSINESS WIRE)--ModMed®, a leader in healthcare technology, announced today that its electronic healthcare…

7 hours ago

Miami Medical Waste Disposal Specialists Address Rising Needlestick Injuries With Crucial Guide

The CDC Estimates Around 385,000 Needlestick and Sharps-Related Injuries Among Healthcare Workers Annually in the…

7 hours ago

TruBridge Names Merideth Wilson as Financial Health General Manager

Brings 25 Years of Healthcare Technology Leadership to CompanyMOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a…

10 hours ago

Rebuff Reality Announces Next-Gen Motion Game Console BodyLink is Now Available on Kickstarter

MIAMI, Jan. 2, 2025 /PRNewswire/ -- Motion game consoles, now relics of the past, once…

10 hours ago

Invivo and TX Studio Versions 6.5 and Earlier to Reach End of Life on March 31, 2025

SANTA CLARA, Calif., Jan. 2, 2025 /PRNewswire/ -- Osteoid Inc. announces that Invivo and TX Studio…

10 hours ago